CD8A and neoplasm: In concert, the increased Renilla Luciferase signal at the tumor site in the animals treated with 3KO OT-1 CD8+ T cells supports the conclusion that the genetic ablation of PD-1, LAG-3, and TIM-3 improves the ability of the CD8+ T cells to enrich in the tumor and to persist at the tumor site.